Dr Baljevic on the PERSEUS Trial in Untreated Multiple Myeloma

Muhamed Baljevic, MD, FACP, discusses the phase 3 PERSEUS trial in patients with previously untreated multiple myeloma.

Related Keywords

United States ,America ,Muhamed Baljevic ,Vanderbilt Amyloidosis Multidisciplinary Program ,Division Of Hematology Oncology ,Vanderbilt Ingram Cancer Center ,Oncologic Drugs Advisory Committee ,Vanderbilt Ingram Cancer Center Protocol ,Plasma Cell Disorders Research ,Hematology Oncology ,Vanderbilt Ingram Cancer Center Protocol Review ,Monitoring System ,North America ,Drugs Advisory Committee ,